Skip to main content
TipRanks
Go Ultimate75% OFF

Trial Holdings Inc. (141A) AI Stock Analysis

2 Followers
JP:141A

Trial Holdings Inc.

(TSE/TYO:141A)

Select Model
Rating:54Neutral
Price Target:JPY 4,213.00â–²(6.93% Upside)
Action:reiterated
Date:11/18/26

Overall score is held back primarily by elevated balance-sheet leverage and a sharp deterioration in net profitability despite strong revenue growth and improved 2026 cash generation. Technicals are supportive (price above key moving averages with positive MACD), but the high P/E and modest dividend yield limit the valuation component.

Positive Factors
Strong Revenue GrowthStrong and accelerating revenue growth indicates expanding business activity and customer demand. If maintained, this momentum can support operating scale, strengthen market presence, and provide a durable foundation for future profit improvement despite current earnings pressure.
Negative Factors
Sharp Leverage IncreaseThe sharp increase in leverage raises financial risk and reduces flexibility because debt has grown much faster than equity. Higher balance-sheet obligations can constrain future investment and make the company more sensitive to weaker operating conditions or earnings volatility.

Trial Holdings Inc. (141A) vs. iShares MSCI Japan ETF (EWJ)

-20%0%20%40%60%80%100%120%JP:141A+67.50%EWJ+15.53%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 495.43B
Dividend Yield
0.43%
Average Volume (3M)
668.47K
Price to Earnings (P/E)
57.2
Beta (1Y)
0.36
Revenue Growth
48.11%
EPS Growth
13.12%
Country
Japan
Employees
9,434
Sector
Consumer Defensive
Sector Strength
62
Industry
Discount Stores

Trial Holdings Inc. Business Overview & Revenue Model

Company Description

Trial Holdings Inc. is a diversified enterprise actively engaged across several key sectors, including retail commerce, supply chain management, financial technology services, and specialized retail technology solutions. The company manages an extens...

Trial Holdings Inc. Financial Statement Overview

Summary

Income statement and cash flow show strong revenue momentum and a rebound in operating/free cash flow in 2026, but the balance sheet is a major constraint: leverage rose sharply with very high debt-to-equity and weaker ROE. Net profitability also deteriorated materially in 2026, raising earnings quality and consistency risk.

Income Statement

60Neutral

Balance Sheet

35Negative

Cash Flow

58Neutral
Financial statement breakdown
BreakdownTTMJun 2025Jun 2024Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue1.36T1.36T720.44B806.59B655.48B597.69B
Gross Profit337.38B337.38B134.00B155.13B117.53B103.49B
EBITDA71.27B69.13B30.78B33.73B25.03B21.58B
Net Income3.52B3.52B11.44B11.75B8.09B7.13B
Balance Sheet
Total Assets807.82B807.82B283.63B300.28B200.64B185.73B
Cash, Cash Equivalents and Short-Term Investments68.90B68.90B91.95B72.33B23.90B27.43B
Total Debt394.63B394.63B16.16B38.56B19.61B24.44B
Total Liabilities673.45B673.45B165.44B171.25B132.62B126.02B
Stockholders Equity130.90B130.90B115.68B126.13B65.89B57.96B
Cash Flow
Free Cash Flow047.10B36.90B-38.41B2.55B10.01B
Operating Cash Flow092.06B59.50B-4.45B18.45B22.34B
Investing Cash Flow0-405.01B-26.00B-35.89B-16.77B-13.49B
Financing Cash Flow0309.39B34.50B20.77B-5.19B-4.32B

Trial Holdings Inc. Technical Analysis

Technical Analysis SentimentPositive
Last Price3940.00

Price Trends

50DMA3869.80Positive
100DMA3590.79Positive
200DMA3635.33Positive

Market Momentum

MACD82.56Positive
RSI49.45Neutral
STOCH14.08Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:141A, the sentiment is Positive. The current price of 3940.00 is below the 20-day moving average (MA) of 3969.25, above the 50-day MA of 3869.80, and above the 200-day MA of 3635.33, indicating a neutral trend. The MACD of 82.56 indicates Positive momentum. The RSI at 49.45 is Neutral, neither overbought nor oversold. The STOCH value of 14.08 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:141A.

Trial Holdings Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

JP:141A against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:9974JP:997478OutperformJPY 140.85B12.63―1.90%4.94%-9.98%
JP:8198JP:819876OutperformJPY 99.45B12.69―2.72%0.90%-28.84%
JP:8242JP:824272OutperformJPY 349.12B8.6012.34%1.68%-0.44%172.74%
JP:8194JP:819471OutperformJPY 234.81B21.61―2.51%2.59%0.10%
JP:7532JP:753270NeutralJPY 2.59T22.7415.65%1.17%11.10%10.49%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
JP:141AJP:141A54NeutralJPY 484.09B57.17―0.43%48.11%13.12%

* Consumer Defensive Sector Average

Performance Comparison

0%50%100%JP:141AJP:7532JP:8242JP:8194JP:8198JP:9974Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:141A and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:141ATrial Holdings Inc.3940.001689.2775.05%
JP:7532Pan Pacific International Holdings Corporation811.50-87.26-9.71%
JP:8242H2O Retailing Corporation2862.00818.1140.03%
JP:8194Life Corporation2714.00286.8111.82%
JP:8198Maxvalu Tokai Co., Ltd.3125.00-428.37-12.06%
JP:9974BELC Co., Ltd.6750.00-581.02-7.93%

Trial Holdings Inc. Corporate Events

TRIAL Holdings Reports Quarterly Sales Growth and Profit

Nov 12, 2026

TRIAL Holdings reported consolidated net sales of ¥355,432 million for the three months ended September 30, 2026, up 8.8% year on year, while EBITDA rose 40.9% to ¥20,712 million. Operating profit increased 107.0% to ¥10,639 million and ordinary prof...

TRIAL Reports Consecutive Same-Store Sales Growth at TRIAL and SEIYU

Nov 10, 2026

TRIAL Holdings operates in distribution and retail, selling grocery, daily products, fresh food, ready meals, household essentials, hardware and apparel through TRIAL and SEIYU stores. The business serves customers through Super Center and smart form...

TRIAL Holdings Completes Seiyu Subsidiary Restructuring

Nov 2, 2026

TRIAL Holdings said an absorption-type company split involving its subsidiaries became effective on November 1, 2026, completing a restructuring linked to the partial liquidation of real estate held by Seiyu. Renamed Seiyu Co., Ltd. assumed the forme...

Trial Holdings Extends Same-Store Sales Rally as New Super Centers Open

Oct 9, 2026

Trial Holdings reported continued same-store sales growth across its TRIAL and SEIYU chains in the first half of fiscal 2027, driven by strong demand for fresh foods, ready meals and private-brand offerings despite unusually wet weather and cooler te...

TRIAL Holdings Details Majority Ownership and Minority Shareholder Safeguards

Sep 25, 2026

TRIAL Holdings, Inc. has disclosed that THC Corporation, an asset management company owned by President Hiro Nagata and his relatives, is its controlling shareholder with 53.76% of voting rights. The announcement clarifies that there are currently no...

Trial Holdings Books Internal Dividend and Loan Provisions With No Impact on Group Earnings

Sep 11, 2026

Trial Holdings, Inc. has recorded dividend income of 7,500 million yen from its consolidated subsidiary Trial Company, Inc. in its non-consolidated results for FY6/2026, while simultaneously booking a 5,461 million yen provision for doubtful accounts...

TRIAL Holdings Posts Sustained Sales Growth as Value Offerings Drive Traffic

Sep 10, 2026

TRIAL Holdings reported continued year-on-year sales growth across its TRIAL and SEIYU stores, underpinned by rising customer traffic and strong demand for fresh foods, ready meals and private-brand items despite varied weather conditions and disrupt...

TRIAL Holdings to Monetize Seiyu Real Estate and Restructure Subsidiaries to Cut Debt

Aug 21, 2026

TRIAL Holdings has approved a restructuring of its Seiyu sub-subsidiary to partially monetize Seiyu’s real estate, seeking to raise about ¥17 billion to relieve the sharp increase in interest-bearing debt that followed the 2025 Seiyu acquisition. The...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 17, 2026